companydata.dkcompanydata.dk

Mundipharma A/S: Financial statements 2025

CVR: 17981994

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Mundipharma A/S (CVR 17981994) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. That is a decrease of 2% compared with the year before. The profit margin was 2.6%. Equity in the 2025 report amounted to DKK 38,165,000. The solvency ratio was 74.3%. The company had 3 employees in the financial year.

Revenue
DKK 25,912,000
Gross Profit
DKK 4,352,000
Profit/Loss
DKK 672,000
Equity
DKK 38,165,000
Total Assets
DKK 51,353,000
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202525.9M4.4M672K38.2M3
202426.4M3.1M514K37.5M2
202335.9M3.1M897K37M2
202240.1M6.8M709K49.8M4
202148.5M10.5M910K49.1M9

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Mundipharma A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Elliot James Haddock joins the board of Mundipharma A/SNov 28, 2025

As of November 28, 2025, Elliot James Haddock has joined the board of directors of Mundipharma A/S.

Sarah Anna Heidrich leaves the board of Mundipharma A/SNov 28, 2025

As of November 28, 2025, Sarah Anna Heidrich has left the board of directors of Mundipharma A/S.

Mundipharma A/S wins public contractNov 26, 2025

Mundipharma A/S has won the tender "Amgros 2026 1.607.a" issued by Amgros I/S worth 60,481,552 DKK.

Mundipharma A/S wins public contractOct 29, 2025

Mundipharma A/S has won the tender "Amgros 2026 1.1203.a" issued by Amgros I/S worth 368,505,024 DKK.

Mundipharma A/S wins public contractOct 24, 2025

Mundipharma A/S has won the tender "Amgros 2026 2.690.b" issued by Amgros I/S worth 217,081,515 DKK.

Mundipharma A/S: The 2024 annual report is outJun 3, 2025

Mundipharma A/S has published its annual report for 2024. Revenue came to DKK 26,430,000, and the net result was DKK 514,000.

Stephen Johan Jamieson joins the board of Mundipharma A/SMar 7, 2025

As of March 7, 2025, Stephen Johan Jamieson has joined the board of directors of Mundipharma A/S.

Sarah Anna Heidrich joins the board of Mundipharma A/SMar 7, 2025

As of March 7, 2025, Sarah Anna Heidrich has joined the board of directors of Mundipharma A/S.

Jörg Fischer leaves the board of Mundipharma A/SMar 7, 2025

As of March 7, 2025, Jörg Fischer has left the board of directors of Mundipharma A/S.

Stephen Johan Jamieson leaves the board of Mundipharma A/SMar 6, 2025

As of March 6, 2025, Stephen Johan Jamieson has left the board of directors of Mundipharma A/S.

About Mundipharma A/S

Mundipharma A/S is a Danish company of the type Aktieselskab based in Vedbæk, founded in 1994. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Norpharma A/S and NORPHARMA A/S. The management consists of Lisbeth Kattenhøj. The board consists of Stephen Johan Jamieson (chair), Bryan George Lea and Lisbeth Kattenhøj. The company is owned by Halm S.à.r.l., RSS Captain Trust Holdings LLC and JDS Captain Trust Holdings LLC. The company has 3 employees (2026). In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. Equity in the 2025 report amounted to DKK 38,165,000.

Source: annual report 2025, Danish Business Authority